Skip to content

AI biotech Enveda raises $311M to advance nature-derived drug candidates

The Boulder-based company values its AI platform for discovering compounds in nature at $2 billion while testing treatments for skin conditions and weight loss.

2 publishers · 2 articles · first seen 23 Sept 2026 · updated 3h ago

Sources

Every article we clustered into this story. Headlines link to the publisher.

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials TechCrunch · 3h ago
AI drug discovery startup Enveda raised $311 million, doubling its valuation to $2 billion Quartz 8h ago

In this story

Enveda